Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -22,6 +22,9 @@
22	22	Jubilant Pharmova Limited has a team of around 7,700 multicultural people across the globe and is committed to delivering value to its customers in over 100 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies worldwide.
23	23
24	24
	25	+[[image:JUBLPHARMA1.png]]
	26	+
	27	+
25	25	= Business Segments =
26	26
27	27	== Pharmaceuticals ==
...	...	@@ -73,7 +73,6 @@
73	73	* Synthetic & Developmental Chemistry
74	74	* Pharmacology
75	75
76		-
77	77	Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic institutions and research foundations.
78	78
79	79
...	...	@@ -106,6 +106,9 @@
106	106	The global crop protection chemicals market size was US$ 58.4 billion in 2019 and is anticipated to expand at a CAGR of 3.3% from 2020 to 2027. Greater emphasis on high crop output to counter food security is the key growth driver.
107	107
108	108
	111	+[[image:JUBLPHARMA2.png]]
	112	+
	113	+
109	109	= Financial Overview =
110	110
111	111
...	...	@@ -134,6 +134,9 @@
134	134	The Drug Discovery & Development Solutions (DDDS) segment includes its Drug Discovery Services (Jubilant Biosys Limited and Jubilant Chemsys Limited) & Proprietary Drug Discovery (Jubilant Therapeutics Inc.) businesses. Revenues in FY 2020 were at Rs 2,615 million as compared to Rs 2,168 million in the previous year, up 21% YoY.
135	135
136	136
	142	+[[image:JUBLPHARMA3.png]]
	143	+
	144	+
137	137	== FY21 results ==
138	138
139	139